FEATUREDPHARMACEUTICALSAstraZeneca makes ~$10B offer for rare-obesity drugmaker Rhythm PharmaceuticalsCollen GezaNovember 6, 2026November 6, 2026 by Collen GezaNovember 6, 2026November 6, 2026